Taken together, it is reasonable to conclude that PRRSV activates NF-κB at late phases of infection and that PRRSV may have developed sophisticated strategies to either activate or inhibit NF-κB for its own benefit at different stages of its life cycle. This evidence concerns the gene NFKB1 and infection.